<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="192581">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00585247</url>
  </required_header>
  <id_info>
    <org_study_id>NIH-LAMMP-2006-4815</org_study_id>
    <nct_id>NCT00585247</nct_id>
  </id_info>
  <brief_title>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks</brief_title>
  <acronym>Aldara</acronym>
  <official_title>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Port wine stains are red birthmarks that without treatment persist for a lifetime. They are
      frequently found on the face and can be conspicuous and disfiguring, negatively impacting
      social interactions for these patients. Treating Port wine stains is difficult. The standard
      of care is to use laser treatment, but over 80% of patients fail to completely clear despite
      multiple treatments. The growth of additional blood vessels (angiogenesis) following the
      Laser treatment is likely an important factor in why these lesions persist despite therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Imiquimod is a topical cream that affects the immune response and has been noted to inhibit
      blood vessel formation. It has been used to successfully treat other vascular growths such
      as hemangiomas. The research can use imiquimod cream 5% cream apply to port wine stains
      after laser therapy to improve lightening of port wine stains. The imiquimod 5% cream cream
      apply to Port wine stains everyday for 8 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Port Wine Stain Blanching</measure>
    <time_frame>8 weeks</time_frame>
    <description>The percentage of Port Wine Stain Blanching (in increments of 10%) compare mean baseline reflectance measurements to post-treatment reflectance measurements.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Port Wine Stain</condition>
  <arm_group>
    <arm_group_label>Imiquimod</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Imiquimod</intervention_name>
    <description>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks</description>
    <arm_group_label>Imiquimod</arm_group_label>
    <other_name>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Port Wine Stain birthmark

          -  Male and female subjects of any age who are in good health.

          -  Fitzpatrick skin type I-VI

        Exclusion Criteria:

          -  Pregnant or lactating

          -  History of cutaneous photosensitivity

          -  History of hypersensitivity to imiquimod 5% cream or any of its components

          -  History of photodermatoses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen M Kelly, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute University of California Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute Medical and Surgical Cilnic</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/22244840</url>
    <description>Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod</description>
  </link>
  <results_reference>
    <citation>Tremaine AM, Armstrong J, Huang YC, Elkeeb L, Ortiz A, Harris R, Choi B, Kelly KM. Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol. 2012 Apr;66(4):634-41. doi: 10.1016/j.jaad.2011.11.958. Epub 2012 Jan 14.</citation>
    <PMID>22244840</PMID>
  </results_reference>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 5, 2015</lastchanged_date>
  <firstreceived_date>December 18, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>Kristen Kelly, M.D., Professor Departments of Dermatology and Surgery</investigator_title>
  </responsible_party>
  <keyword>birthmarks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Port-Wine Stain</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Imiquimod</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
